Recurrent and/or metastatic thyroid cancer: therapeutic options.

Recurrent and/or metastatic thyroid cancer: therapeutic options.

Thyroid cancer is relatively rare, accounting for 0.5 - 10 cases per 100,000 individuals per year. Despite their generally favourable prognosis, patients with differentiated thyroid cancer are at risk of tumour recurrence for decades after diagnosis. The optimal management remains controversial even...

書誌詳細
主要な著者:	Karavitaki, N, Vlassopoulou, V, Tzanela, M, Tzavara, I, Thalassinos, N
フォーマット:	Journal article
言語:	English
出版事項:	2002

類似資料

Molecular staging using qualitative RT-PCR analysis detecting thyreoglobulin mRNA in the peripheral blood of patients with differentiated thyroid cancer after therapy.
著者:: Karavitaki, N, 等
出版事項: (2005)

Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome.
著者:: Tzanela, M, 等
出版事項: (2004)

Evaluation of GH reserve in patients with adrenal incidentalomas and biochemical evidence of subclinical autonomous glucocorticoid hypersecretion.
著者:: Tzanela, M, 等
出版事項: (2005)

Novel therapeutic options for recurrent metastatic salivary gland tumors: Review of ongoing clinical trials
著者:: Avinash Pandey, 等
出版事項: (2018-01-01)

THERAPEUTIC OPTIONS FOR INVASIVE BREAST CANCER
著者:: Ganusevich O. N., 等
出版事項: (2019-05-01)

Metastatic bone disease: Pathogenesis and therapeutic options
著者:: Stella D'Oronzo, 等
出版事項: (2019-04-01)

Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy
著者:: Naimah Turner, 等
出版事項: (2024-05-01)

Gliadin encapsulated PCOs nanoformulation: An effective therapeutic option for metastatic breast cancer
著者:: Sant Lal, 等
出版事項: (2025-06-01)

Therapeutic options in older patients with metastatic non-small cell lung cancer
著者:: Elisabeth Quoix
出版事項: (2012-09-01)

Radiofrequency Ablation of Recurrent Metastatic Papillary Thyroid Cancer to a Lymph Node
著者:: Shahzad Ahmad, MD, 等
出版事項: (2022-11-01)

Targeted therapeutic options in early and metastatic NSCLC-overview
著者:: Gabriella Gálffy, 等
出版事項: (2024-03-01)

Metastatic BRAF V600E-Mutated Thyroid Carcinoma: Molecular/Genetic Profiling Brings a New Therapeutic Option
著者:: Joana S. Reis, 等
出版事項: (2022-11-01)

Standard-of-Care Treatment for HER2+ Metastatic Breast Cancer and Emerging Therapeutic Options
著者:: Sarah K Premji, 等
出版事項: (2024-02-01)

Emerging Treatment Options for the Treatment of Metastatic Urothelial Cancer: Therapeutic Potential of Enfortumab Vedotin
著者:: Jain RK, 等
出版事項: (2020-09-01)

Pelvic Exenteration in Advanced, Recurrent or Synchronous Cancers—Last Resort or Therapeutic Option?
著者:: Vlad Rotaru, 等
出版事項: (2024-08-01)

Therapy options for metastatic triple negative breast cancer
著者:: E. V. Glazkova, 等
出版事項: (2022-06-01)

Thyroid Cancer Presenting with Concomitant Metastatic Breast Cancer in the Thyroid
著者:: Chung-Chen Wang, 等
出版事項: (2014-12-01)

Metastatic papillary thyroid cancer presenting with a recurrent necrotic cystic cervical lymph node
著者:: Alexa Clark, 等
出版事項: (2019-07-01)

Current Therapeutic Options in Active Moderate-to-Severe Thyroid-Associated Ophthalmopathy
著者:: Stoynova M., 等
出版事項: (2023-12-01)

2012 European Thyroid Association Guidelines for Metastatic Medullary Thyroid Cancer
著者:: V V Voskoboynikov, 等
出版事項: (2013-06-01)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
著者:: Faiza Naseer, 等
出版事項: (2021-11-01)

Choice of treatment options for metastatic hormone-sensitive prostate cancer
著者:: R. A. Gafanov, 等
出版事項: (2020-12-01)

Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis.
著者:: Lixian Zhong, 等
出版事項: (2013-01-01)

Metastatic lymph node characteristics as predictors of recurrence/persistence in the neck and distant metastases in differentiated thyroid cancer
著者:: Mayara Peres Barbosa, 等

Metastatic Thyroid Cancer In A Man With Tumor-Free Thyroid
著者:: Spenser S. Souza, MS, 等
出版事項: (2020-09-01)

Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome.
著者:: Karavitaki, N, 等
出版事項: (2004)

High-throughput screening for the identification of new therapeutic options for metastatic pheochromocytoma and paraganglioma.
著者:: Alessio Giubellino, 等
出版事項: (2014-01-01)

RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
著者:: Paula Colón-Bolea, 等
出版事項: (2021-10-01)

NEW THERAPEUTIC OPTIONS IN THE TREATMENT OF METASTATIC LIMB SARCOMAS: A CASE SERIES
著者:: Nicola Ratto
出版事項: (2013-04-01)

Occult Metastatic Papillary Thyroid Cancer in an Adolescent
著者:: Anna Chin, MD, MPH, 等
出版事項: (2024-01-01)

Current management options in metastatic renal cell cancer
著者:: Sittu Govindasamy Dinakaran Gangadaran
出版事項: (2017-06-01)

Trifluridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An efficacy and safety analysis
著者:: Daniel Sur, 等
出版事項: (2022-10-01)

Endometrioid Adenocarcinoma Metastatic to the Thyroid, Presenting Like Anaplastic Thyroid Cancer
著者:: Natasha Pollak, 等
出版事項: (2011-01-01)

Thyroid crisis caused by metastatic thyroid cancer: an autopsy case report
著者:: Kai Takedani, 等
出版事項: (2021-10-01)

Metastatic colorectal cancer to a primary thyroid cancer
著者:: Swain Sarah, 等
出版事項: (2008-11-01)

Phenotypic characterization of metastatic anaplastic thyroid cancer stem cells.
著者:: Wen Li, 等
出版事項: (2013-01-01)

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer
著者:: Nils Degrauwe, 等
出版事項: (2012-06-01)

Clinical observation of metastatic thyroid disease in a patient with breast cancer
著者:: E. V. Bondarenko, 等
出版事項: (2018-09-01)

Selpercatinib – a new option for a precision approach to the treatment of medullary thyroid cancer
著者:: A. K. Plugar, 等
出版事項: (2024-12-01)

Recurrent follicular thyroid carcinoma metastatic to axillary lymph nodes mimicking pulmonary adenocarcinoma
著者:: Stephanie J Kim, 等
出版事項: (2021-02-01)